Ashleigh Palmer Provention Bio, Inc. (PRVB) insider trading activity

Ashleigh Palmer is Director and CEO of Provention Bio, Inc.. Currently has a direct ownership of 0 shares of PRVB, which is worth approximately $0. The most recent transaction as insider was on Apr 27, 2023, when has been sold 2,570,050 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Ashleigh Palmer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 27 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	2,570,050 Reduced 100.0%	0 Common Stock
Feb 13 2023	SELL Open market or private sale	$259,383 $10.04 p/Share	25,835 Reduced 1.0%	2,570,050 Common Stock
Feb 13 2023	BUY Exercise of conversion of derivative security	$64,587 $2.5 p/Share	25,835 Added 0.99%	2,595,885 Common Stock
Feb 10 2023	SELL Open market or private sale	$505,500 $10.11 p/Share	50,000 Reduced 1.91%	2,570,050 Common Stock
Feb 10 2023	BUY Exercise of conversion of derivative security	$125,000 $2.5 p/Share	50,000 Added 1.87%	2,620,050 Common Stock
Jan 18 2023	SELL Open market or private sale	$248,174 $10.27 p/Share	24,165 Reduced 0.93%	2,570,050 Common Stock
Jan 18 2023	BUY Exercise of conversion of derivative security	$60,412 $2.5 p/Share	24,165 Added 0.92%	2,594,215 Common Stock
Nov 30 2021	BUY Open market or private purchase	$24,975 $6.66 p/Share	3,750 Added 0.15%	2,570,050 Common Stock

Ashleigh Palmer

Director and CEO

Red Bank, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRVB shares.

Notify only if

Value

Insider Trading

Get notified when an Provention Bio, Inc. insider buys or sells PRVB shares.

Notify only if

Operation

Value

Type

News

Receive news related to Provention Bio, Inc.

Track Activities on PRVB

Account